AGRX
Agile Therapeutics
AGRX
AGRX
Delisted
AGRX was delisted on the 25th of March, 2024.
21 hedge funds and large institutions have $496K invested in Agile Therapeutics in 2023 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
Holders
21
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$115K | |
| 2 | +$39.9K | |
| 3 | +$19.5K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$12.5K |
| 5 |
JPMorgan Chase & Co
New York
|
+$8.27K |
Top Sellers
| 1 | -$575 | |
| 2 | -$82 | |
| 3 | -$2 | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$2 |